Milan, Italy

Annalisa Noce


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Annalisa Noce: Innovating COVID-19 Treatments in Milan

Introduction

Annalisa Noce is a noted inventor based in Milan, Italy, who has made significant contributions to the medical field with her innovative ideas. With a focus on developing effective treatments, she has been working on solutions to combat the effects of COVID-19. Her dedication to research and development has led to the patenting of a groundbreaking method that holds promise for improving patient outcomes.

Latest Patents

Annalisa Noce holds one patent titled "Method for the treatment of COVID-19 infections with palmitoylethanolamide." This innovative approach focuses on treating COVID-19 infections through the administration of a mixture of ultra-micronized palmitoylethanolamide and micronized palmitoylethanolamide. The method emphasizes using an endogenous compound that is devoid of significant toxicity, which is essential for patient safety and effective treatment.

Career Highlights

Currently, Annalisa is associated with Epitech Group S.p.a., a company that specializes in cutting-edge solutions in the medical field. Her role in the organization has allowed her to work on revolutionary projects aimed at enhancing healthcare applications and addressing significant health challenges, including the ongoing pandemic.

Collaborations

Throughout her career, Annalisa Noce has collaborated with esteemed colleagues, including Francesco Della Valle and Maria Federica Della Valle. Their combined expertise and commitment to innovation have fostered a creative atmosphere that promotes the development of new solutions to complex health issues.

Conclusion

Annalisa Noce's work exemplifies the spirit of innovation crucial in today’s fast-evolving medical landscape. Her patent on a novel method for treating COVID-19 infections demonstrates her commitment to improving patient care through research and development. As she continues her journey at Epitech Group S.p.a., the impact of her inventions will surely resonate within the medical community and beyond.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…